Table 1.
Baseline Characteristics
| All patients | CAN (n=67) | AML (n=64) | P value | |
|---|---|---|---|---|
| Age at baseline (years) | 73±9 | 72±10 | 73±8 | 0.519 |
| Male sex (%) | 85.6 | 85.1 | 86.2 | 0.111 |
| Body weight (kg) | 61.9±11.3 | 61.3±11.9 | 62.5±10.7 | 0.589 |
| eGFR (mL/min/1.73 m2) | 62.9±15.9 | 65.4±16.4 | 60.2±15.1 | 0.691 |
| LDL (mg/dL) | 110.4±30.1 | 112.2±34.1 | 108.3±25.1 | 0.881 |
| SBP (mmHg) | 130.2±16.8 | 129.5±17.7 | 130.9±1.0 | 0.631 |
| DBP (mmHg) | 74.2±12.7 | 73.2±12.1 | 75.2±13.2 | 0.938 |
| AAA diameter (cm) | 0.262 | |||
| Mean±SD | 3.72±0.58 | 3.66±0.58 | 3.78±0.57 | |
| Median [IQR] | 3.69 [2.78–6.38] | 3.56 [2.78–5.48] | 3.82 [2.79–6.38] | |
| No. patients | 131 | 67 | 64 | |
| Without β-blockers | 0.890 | |||
| Mean±SD | 3.75±0.60 | 3.74±0.67 | 3.76±0.70 | |
| Median [IQR] | 3.70 [2.78–6.38] | 3.68 [2.78–5.48] | 3.80 [2.79–6.38] | |
| No. patients | 93 | 49 | 44 | |
| HbA1c (%) | 5.6±0.6 | 5.6±0.5 | 5.6±0.7 | 0.68 |
| CAD | 1 (0.76) | 1 (1.49) | 0 (0.0) | 0.23 |
| Smoking | 94 (72.0) | 48 (71.6) | 46 (72.3) | 0.549 |
Unless indicated otherwise, data are given as n (%) or mean±SD. P values for comparisons between the AML and CAN groups were obtained from t‐tests. AAA, abdominal aortic aneurysm; AML, amlodipine; CAD, coronary artery disease; CAN, candesartan; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; IQR, interquartile range; LDL, low-density lipoprotein; SBP, systolic blood pressure.